These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 22071603)

  • 1. Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation.
    Han ZB; Chen HY; Fan JW; Wu JY; Tang HM; Peng ZH
    J Cancer Res Clin Oncol; 2012 Jan; 138(1):153-61. PubMed ID: 22071603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation.
    Han ZB; Zhong L; Teng MJ; Fan JW; Tang HM; Wu JY; Chen HY; Wang ZW; Qiu GQ; Peng ZH
    Mol Oncol; 2012 Aug; 6(4):445-57. PubMed ID: 22552153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma.
    Fan MQ; Huang CB; Gu Y; Xiao Y; Sheng JX; Zhong L
    J Exp Clin Cancer Res; 2013 Apr; 32(1):21. PubMed ID: 23594563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and survival prediction of microRNA-155 in hepatocellular carcinoma after liver transplantation].
    Han ZB; Chen HY; Fan JW; Wu JY; Peng ZH; Wang ZW
    Zhonghua Yi Xue Za Zhi; 2013 Mar; 93(12):884-7. PubMed ID: 23863669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma.
    Huang CS; Yu W; Cui H; Wang YJ; Zhang L; Han F; Huang T
    Int J Clin Exp Pathol; 2015; 8(6):7234-8. PubMed ID: 26261620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation.
    Ng KT; Lo CM; Wong N; Li CX; Qi X; Liu XB; Geng W; Yeung OW; Ma YY; Chan SC; Man K
    Oncotarget; 2016 Apr; 7(15):19824-39. PubMed ID: 26918346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-203 expression predicts outcome after liver transplantation for hepatocellular carcinoma in cirrhotic liver.
    Chen HY; Han ZB; Fan JW; Xia J; Wu JY; Qiu GQ; Tang HM; Peng ZH
    Med Oncol; 2012 Sep; 29(3):1859-65. PubMed ID: 21786180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of microRNA-372 associates with tumor progression and prognosis in hepatocellular carcinoma.
    Gu H; Guo X; Zou L; Zhu H; Zhang J
    Mol Cell Biochem; 2013 Mar; 375(1-2):23-30. PubMed ID: 23291979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-transplant infection improves outcome of hepatocellular carcinoma patients after orthotopic liver transplantation.
    Chao JS; Zhao SL; Ou-Yang SW; Qian YB; Liu AQ; Tang HM; Zhong L; Peng ZH; Xu JM; Sun HC
    World J Gastroenterol; 2019 Oct; 25(37):5630-5640. PubMed ID: 31602163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A microRNA biomarker of hepatocellular carcinoma recurrence following liver transplantation accounting for within-patient heterogeneity.
    Xie QY; Almudevar A; Whitney-Miller CL; Barry CT; McCall MN
    BMC Med Genomics; 2016 Apr; 9():18. PubMed ID: 27059462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma.
    Li BK; Huang PZ; Qiu JL; Liao YD; Hong J; Yuan YF
    Diagn Pathol; 2014 Dec; 9():226. PubMed ID: 25466449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-106b-5p promotes aggressive progression of hepatocellular carcinoma via targeting RUNX3.
    Gu H; Gu S; Zhang X; Zhang S; Zhang D; Lin J; Hasengbayi S; Han W
    Cancer Med; 2019 Nov; 8(15):6756-6767. PubMed ID: 31503422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Dickkopf-1 predicts poor prognosis for patients with hepatocellular carcinoma after orthotopic liver transplantation by promoting cancer metastasis and recurrence.
    Huang Y; Yang X; Zhao F; Shen Q; Wang Z; Lv X; Hu B; Yu B; Fan J; Qin W
    Med Oncol; 2014 Jul; 31(7):966. PubMed ID: 24878698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of microRNA-130b correlates with poor prognosis of patients with hepatocellular carcinoma.
    Wang WY; Zhang HF; Wang L; Ma YP; Gao F; Zhang SJ; Wang LC
    Diagn Pathol; 2014 Aug; 9():160. PubMed ID: 25123453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of miR-3607 predicts prognosis of hepatocellular carcinoma and regulates tumor cell proliferation, migration and invasion.
    Dou W; Yang M; Su Y; Xie R
    Diagn Pathol; 2020 May; 15(1):54. PubMed ID: 32404179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic role of microRNA-423-5p in hepatocellular carcinoma.
    Wu LM; Ji JS; Yang Z; Xing CY; Pan TT; Xie HY; Zhang F; Zhuang L; Zhou L; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):613-8. PubMed ID: 26663009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
    Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
    Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-744 is a potential prognostic marker in patients with hepatocellular carcinoma.
    Tan YL; Bai ZG; Zou WL; Ma XM; Wang TT; Guo W; Liu J; Li JS; Jie-Yin ; Zang YJ; Zhang ZT
    Clin Res Hepatol Gastroenterol; 2015 Jun; 39(3):359-65. PubMed ID: 25543521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence-free survival after hepatectomy.
    Yuan SX; Yang F; Yang Y; Tao QF; Zhang J; Huang G; Yang Y; Wang RY; Yang S; Huo XS; Zhang L; Wang F; Sun SH; Zhou WP
    Hepatology; 2012 Dec; 56(6):2231-41. PubMed ID: 22706893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.